Single-Center Study of Safety and Anti-tumor Activity of Nivolumab in Patients with Advanced Hepatocellular Carcinoma or Cholangiocarcinoma

被引：0
|
作者：
Soe, Eiei P. [1 ]
Gu, Ping [2 ]
Park, James [2 ]
机构：
[1] NYU, Langone Med Ctr, Brooklyn, NY USA
[2] NYU, Langone Med Ctr, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-02474
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2474
引用
收藏
页码：S1262 / S1262
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
    Rodrigo Imedio, Esteban
    Diaz Beveridge, Roberto
    Aparicio Urtasun, Jorge
    Bruixola Campos, Gema
    Lorente Estelles, David
    Fonfria Esparcia, Maria
    Caballero Daroqui, Javier
    Segura Huerta, Angel
    Gimenez Ortiz, Alejandra
    Montalar Salcedo, Joaquin
    MEDICAL ONCOLOGY, 2014, 31 (05) : 1 - 6
  • [32] Combining radiation therapy with anti-PD-1 for patients with advanced hepatocellular carcinoma: An open-label, single-center, single-arm clinical study.
    Li, Jian-Xu
    Su, Ting-Shi
    Lin, Xiao-Feng
    Chen, Yi-Tian
    Liang, Shi-Xiong
    Xiang, Bang-De
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
    Esteban Rodrigo Imedio
    Roberto Díaz Beveridge
    Jorge Aparicio Urtasun
    Gema Bruixola Campos
    David Lorente Estellés
    María Fonfría Esparcia
    Javier Caballero Daroqui
    Ángel Segura Huerta
    Alejandra Giménez Órtiz
    Joaquin Montalar Salcedo
    Medical Oncology, 2014, 31
  • [34] Efficacy and safety of nivolumab plus ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study
    Yau, T.
    Hsu, C.
    Kang, Y.
    Kim, T.
    Hou, M.
    Lim, H.
    Chao, Y.
    Kim, Y.
    Ikeda, M.
    Choo, S.
    Neely, J.
    Shen, Y.
    Tschaika, M.
    Kudo, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S233 - S233
  • [35] Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study
    Kudo, Masatoshi
    Hsu, Chiun
    Kim, Tae-You
    Choo, Su-Pin
    Kang, Yoon-Koo
    Hou, Ming-Mo
    Yeo, Winnie
    Numata, Kazushi
    Chopra, Akhil
    Baakili, Adyb
    dela Cruz, Christine
    Zhao, Huanyu
    Yau, Thomas
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] SINGLE-CENTER STUDY ON SEX DISPARITIES IN RISK FACTORS FOR HEPATOCELLULAR CARCINOMA
    Bigham, Dakota
    Vinall, Adam
    Ahuja, Roma
    Azeez, Leen S.
    Owo, Chioma S.
    Pedicone, Lisa
    Gomez-Aldana, Andres
    Rodas, Fabian
    Landaverde, Carmen
    Lawitz, Eric
    Poordad, Fred
    Petrasek, Jan
    Tsai, Eugenia
    GASTROENTEROLOGY, 2024, 166 (05) : S1731 - S1731
  • [37] Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study
    Aktas, Gokmen
    Kus, Tulay
    Kalender, Mehmet Emin
    Kervancioglu, Selim
    Sevinc, Alper
    Kul, Seval
    Camci, Celaletdin
    JOURNAL OF BUON, 2017, 22 (01): : 150 - 156
  • [38] Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma
    Yamauchi, Masami
    Ono, Atsushi
    Amioka, Kei
    Fujii, Yasutoshi
    Nakahara, Hikaru
    Teraoka, Yuji
    Uchikawa, Shinsuke
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Okamoto, Wataru
    Miki, Daiki
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Imamura, Michio
    Hayes, C. Nelson
    Ohishi, Waka
    Kishi, Takeshi
    Kimura, Mizuki
    Suzuki, Natsumi
    Arihiro, Koji
    Aikata, Hiroshi
    Chayama, Kazuaki
    Oka, Shiro
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [39] Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma
    Masami Yamauchi
    Atsushi Ono
    Kei Amioka
    Yasutoshi Fujii
    Hikaru Nakahara
    Yuji Teraoka
    Shinsuke Uchikawa
    Hatsue Fujino
    Takashi Nakahara
    Eisuke Murakami
    Wataru Okamoto
    Daiki Miki
    Tomokazu Kawaoka
    Masataka Tsuge
    Michio Imamura
    C. Nelson Hayes
    Waka Ohishi
    Takeshi Kishi
    Mizuki Kimura
    Natsumi Suzuki
    Koji Arihiro
    Hiroshi Aikata
    Kazuaki Chayama
    Shiro Oka
    Communications Medicine, 3
  • [40] Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
    Abdel-Rahman, Omar
    Abdelwahab, Manal
    Shaker, Mohammed
    Abdelwahab, Sherif
    Elbassiony, Mohammed
    Ellithy, Mahmoud
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (01) : 9 - 13
12345